湛彥強(qiáng) 曾非 段申漢 曾慶杏 張兆輝
430060 武漢大學(xué)人民醫(yī)院神經(jīng)內(nèi)一科
以錐體外系為首發(fā)癥狀的家族性棘紅細(xì)胞增多癥2例臨床分析
湛彥強(qiáng) 曾非 段申漢 曾慶杏 張兆輝
目的提高對(duì)首發(fā)為中樞神經(jīng)系統(tǒng)錐體外系表現(xiàn)的棘紅細(xì)胞增多癥的臨床表現(xiàn)、診斷與治療方法及細(xì)胞學(xué)病理學(xué)特征的認(rèn)識(shí)及鑒別。方法報(bào)道2例棘紅細(xì)胞增多癥患者的臨床表現(xiàn)、輔助檢查及診治過程。結(jié)果2例患者為青年兄妹,慢性病程,逐漸加重,主要表現(xiàn)均為舞蹈樣不自主運(yùn)動(dòng),血常規(guī)均可見紅細(xì)胞形態(tài)異常,進(jìn)一步行血液細(xì)胞學(xué)染色,光鏡下可見棘形紅細(xì)胞增多,且隨病程增長(zhǎng),畸形紅細(xì)胞比例逐漸增多,臨床癥狀可能與棘紅細(xì)胞比例有關(guān)。該病例具有家族性,兄妹血液細(xì)胞病理學(xué)特征及臨床表現(xiàn)均類似。結(jié)論對(duì)于年輕舞蹈樣錐體外系病變,需考慮棘紅細(xì)胞增多癥可能,及時(shí)行血液細(xì)胞學(xué)形態(tài)檢查可迅速確診。目前此病尚無有效治療手段,總體預(yù)后不佳。
棘紅細(xì)胞增多癥 舞蹈癥 診斷
神經(jīng)棘紅細(xì)胞增多癥(neuroacanthocytosis)是一種極為少見的進(jìn)行性不自主運(yùn)動(dòng)伴有血液中棘紅細(xì)胞增多為臨床特征的神經(jīng)系統(tǒng)變性疾病[1],自1960年Levine等首次報(bào)道此病以來[2],全世界范圍內(nèi)均可見報(bào)道,本病大多與20~30歲起病,多數(shù)以肢體舞蹈樣動(dòng)作或口唇及舌的不自主運(yùn)動(dòng)為首發(fā)癥狀。本研究現(xiàn)將本院收治的2例以錐體外系不自主運(yùn)動(dòng)為臨床表現(xiàn)的棘紅細(xì)胞增多癥病例進(jìn)行整理及分析,并查閱相關(guān)的文獻(xiàn)報(bào)道及復(fù)習(xí),以期望能提高對(duì)于該病的認(rèn)識(shí)及診斷水平。
2例患者為姐弟關(guān)系,姐姐,32歲,主因“四肢及全身不自主運(yùn)動(dòng)3年”于2012年8月2日收入武漢大學(xué)人民醫(yī)院神經(jīng)內(nèi)一科?;颊卟〕?年,起病年齡約28歲,首發(fā)癥狀為雙上肢抖動(dòng),動(dòng)作不協(xié)調(diào),進(jìn)而逐漸出現(xiàn)吐詞不清晰、飲水嗆咳及四肢全身不自主舞蹈樣運(yùn)動(dòng),但仍能行走,生活基本可自理。
查體:神志清楚,醉酒步態(tài),消瘦,反應(yīng)稍遲鈍,定向力及計(jì)算力正常,吐詞含糊,余顱神經(jīng)未見異常,四肢可見不自主舞蹈樣動(dòng)作,肌張力低,腱反射低,病理征未引出,輪替動(dòng)作笨拙,深淺感覺未見異常。
弟弟,30歲,主因“四肢及全身不自主運(yùn)動(dòng)9年,加重5年”于2012年8月9日收入武漢大學(xué)人民醫(yī)院神經(jīng)內(nèi)一科?;颊卟〕?年,起病年齡約21歲,首發(fā)癥狀為雙上肢抖動(dòng),動(dòng)作不協(xié)調(diào),進(jìn)而逐漸出現(xiàn)吞咽困難、飲水嗆咳、構(gòu)音障礙及四肢全身不自主舞蹈樣運(yùn)動(dòng),伴有口唇運(yùn)動(dòng)增多,進(jìn)食困難,但仍能行走,睡眠后不自主運(yùn)動(dòng)消失,生活無法自理。
查體:神志清楚,消瘦,中度營養(yǎng)不良貌,反應(yīng)稍遲鈍,定向力及計(jì)算力正常,吐詞含糊,口唇及舌可見不自主運(yùn)動(dòng),余顱神經(jīng)未見異常,四肢可見不自主舞蹈樣動(dòng)作,肌張力低,腱反射低,病理征未引出,左上肢指鼻不能,意向性震顫明顯,輪替動(dòng)作笨拙,深淺感覺未見異常。
入院后完善相關(guān)檢查,臨床診斷為棘紅細(xì)胞增多癥,經(jīng)過氟哌啶醇、硫必利以及對(duì)癥支持等治療后患者不自主運(yùn)動(dòng)較前有好轉(zhuǎn)。
輔助檢查:(1)影像學(xué)檢查。頭顱MRI未見明顯異常;(2)血生化檢查。肌酶譜示AST 77 U/L,CK 2509 U/L,LDH 410 U/L,血清銅及銅藍(lán)蛋白均正常,抗O及血沉均正常;(3)電生理檢查。腦電圖及肌電圖檢查未見明顯異常;(4)外周血涂片檢查。外周血紅細(xì)胞形態(tài)異常,可見大量棘紅細(xì)胞(圖1~2),占總數(shù)30%~50%。
舞蹈樣動(dòng)作及棘紅細(xì)胞增多是本病最特征的臨床表現(xiàn)[3],患者多表現(xiàn)為逐漸起病的不規(guī)則、突然性不自主運(yùn)動(dòng),四肢累及較多見,口面部常易累及,導(dǎo)致咬舌、吞咽困難及進(jìn)食困難?;颊咄橇φ#话橛芯裾系K。
患者外周血中出現(xiàn)棘紅細(xì)胞是本病特異性表現(xiàn),且不同病例的棘紅細(xì)胞增多比例差別很大,通常為5%~50%,Hardie等認(rèn)為棘紅細(xì)胞比例超過3%才具有病理學(xué)意義[4]。本研究中兄妹兩人的外周血涂片均可見異常的棘紅細(xì)胞增多,占總數(shù)30%~50%,且發(fā)病時(shí)間越長(zhǎng),棘紅細(xì)胞比例約多,細(xì)胞棘也越多,符合本病特異性表現(xiàn),且臨床癥狀可能與棘紅細(xì)胞比例有關(guān),即兄妹二人中兄發(fā)病時(shí)間更長(zhǎng),臨床癥狀更明顯,棘紅細(xì)胞比例更高。目前的文獻(xiàn)報(bào)道本病是由于VPS13A基因的突變?cè)斐傻某H旧w隱性遺傳疾病。
本病需與風(fēng)濕熱舞蹈病及肝豆?fàn)詈俗冃缘认噼b別,風(fēng)濕因子、血沉及血清銅、銅藍(lán)蛋白檢查可明確。
圖1 高倍顯微鏡下紅細(xì)胞形態(tài)(染色方法?×100倍,左圖為姐姐,右圖為弟弟)
圖2 低倍光鏡下紅細(xì)胞形態(tài)(染色方法?×?倍,左圖為姐姐,右圖為弟弟)
另外,本病例需與Hungtington’s舞蹈病(Hungtinton’s disease,HD)相鑒別,HD是一種常染色體顯性遺傳病[5],好發(fā)于20~50歲,多以雙側(cè)肢體舞蹈開始,伴有精神異常及智能障礙,周圍血紅細(xì)胞形態(tài)多正常,病變定位于4號(hào)染色體。
本病還需要與Mcleod綜合征,Hallervorden-Spatz(HARP)綜合征相鑒別,Mcleod綜合征是一種紅細(xì)胞Kell抗原陰性的X-p21性連鎖顯性遺傳病[6],多于中年起病,口面及四肢舞蹈樣運(yùn)動(dòng)多見,極少有舌唇咬傷及尖叫,可伴有癲癇發(fā)作,一般伴有心肌病及周圍神經(jīng)肌肉的改變,但血液紅細(xì)胞形態(tài)學(xué)正常,無棘紅細(xì)胞。
HARP綜合征是常染色體隱性遺傳病[7],臨床多表現(xiàn)為發(fā)育遲緩、脂肪瘤、視網(wǎng)膜色素斑、慢性進(jìn)行性脊髓小腦綜合征,可伴有周圍神經(jīng)病。頭部MRI檢查可見雙側(cè)蒼白球變性,呈特殊的虎眼征,血液棘紅細(xì)胞陰性。
目前對(duì)本病尚無特效治療,氟哌啶醇可減輕錐體外系癥狀,但無法阻止病情進(jìn)展,有文獻(xiàn)報(bào)道行蒼白球切除術(shù)可減輕舞蹈樣動(dòng)作[8]。
總之,對(duì)于臨床上首發(fā)不自主運(yùn)動(dòng)的年輕患者,除了要考慮舞蹈病及肝豆?fàn)詈俗冃缘瘸R婂F體外系疾病外,需考慮棘紅細(xì)胞增多癥可能,對(duì)于普通基層醫(yī)院,紅細(xì)胞形態(tài)學(xué)檢查對(duì)該病有診斷意義,故借助常規(guī)的外周血涂片及紅細(xì)胞形態(tài)學(xué)檢查即可明確診斷。
[1] Walker RH,Danek A,Dobson-Stone C,et al.Developments in neuroacanthocytosis:expanding the spectrum of choreaticsyndromes[J].Mov Disord,2006,21(11):1794-1805.
[2] Kanjanasut N,Jagota P,Bhidayasiri R.The first case report of neuroacanthocyto sis in Thailand:utilization of a peripheral blood smear technique for detectingacanthocytes[J].Clin Neurol Neurosurg,2010,112(6):541-543.
[3] Walker RH,Rasmussen A,Rudnicki D,et al.Huntington's disease-like 2 can present as chorea-acanthocytosis[J].Neurology,2003,61(7):1002-1004.
[4] Hardie RJ,Pullon H,Harding AE,et al.Neuroacanthocytosis.A clinical,haematological and pathological study of 19 cases [J].Brain,1991,114(Pt1A):13-49.
[5] Walker RH,Rasmussen A,Rudnicki D,et al.Huntington's disease-like 2can present as chorea-acanthocytosis[J].Neurology,2003,61(7):1002-1004.
[6] Ho M,Chelly J,Carter N,et al.Isolation of thegene for McLeod syndrome that encodes a novel membrane transport protein[J].Cell,1994,77(6):869-880.
[7] Storch A,Kornhass M,Schwarz J.Testing for acanthocytosis:a prospectivereader-blinded study in movement disorder patients[J].J Neurol,2005,252(1):84-90.
[8] Fujimoto Y,Isozaki E,Yokochi F,et al.A case of chorea-acanthocytosis successfully treated with posterioventral pallidotomy,Rinsho-Shinkeigaku[J].199,37(10):891-894.
Clinicalanalysisofneuroacanthocytosis:twocasereport
ZhanYanqiang,ZengFei,DuanShenhan,etal.
DepartmentofNeurology,RenminHospital,WuHanUniversity,Wuhan430060
ObjectiveTo provide insight into the clinical manifestation,histopathology characteristics,diagnostic and therapeutic methods of neuroacanthocytosis.MethodsThe clinical,auxiliary examination and pathological data of two patients with neuroacanthocytosis were presented,and the relevant literature was reviewed.ResultsA young male patient had a 9-year history of ingravescent choreiform movement,and his blood routine examination showed dysmorphic red cells.His sister also had a 3-year history of similar symptoms.Further erythrocytic pathological dyeing both showed acanthoid erythrocytes abnormally increased under the light microscope.The amount of abnormal acanthoid erythrocytes accumulated with the progression of disease,which revealed a positive correlation with the clinical symptoms.These two cases also showed a familial aggregation as brother and sister had similar clinical symptoms and pathological staining of erythrocyte.ConclusionNeuroacanthocytosis should be considered in young patients with ingravescent choreiform movement and the earliest erythrocytic pathological dyeing was required for early diagnosis.There were no effective therapeutic methods for neuroacanthocytosis and the prognosis is quite poor.
Neuroacanthocytosis Choreiform movement Diagnosis
R742.2
A
1007-0478(2017)05-0447-03
10.3969/j.issn.1007-0478.2017.05.016
(2016-06-30收稿)